SE462547B - Farmaceutisk komposition bestaaende av vattensvaellbar vattenoloeslig polymer fylld med metylhydroxiprogesteronacetat (map) samt foerfarande foer dess framstaellning - Google Patents

Farmaceutisk komposition bestaaende av vattensvaellbar vattenoloeslig polymer fylld med metylhydroxiprogesteronacetat (map) samt foerfarande foer dess framstaellning

Info

Publication number
SE462547B
SE462547B SE8500553A SE8500553A SE462547B SE 462547 B SE462547 B SE 462547B SE 8500553 A SE8500553 A SE 8500553A SE 8500553 A SE8500553 A SE 8500553A SE 462547 B SE462547 B SE 462547B
Authority
SE
Sweden
Prior art keywords
map
polymer
water
swellable
mixture
Prior art date
Application number
SE8500553A
Other languages
English (en)
Swedish (sv)
Inventor
F Carli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SE462547B publication Critical patent/SE462547B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE8500553A 1984-02-08 1985-02-06 Farmaceutisk komposition bestaaende av vattensvaellbar vattenoloeslig polymer fylld med metylhydroxiprogesteronacetat (map) samt foerfarande foer dess framstaellning SE462547B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848403360A GB8403360D0 (en) 1984-02-08 1984-02-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE462547B true SE462547B (sv) 1990-07-16

Family

ID=10556300

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8500553D SE8500553L (sv) 1984-02-08 1985-02-06 Pharmaceutical composition
SE8500553A SE462547B (sv) 1984-02-08 1985-02-06 Farmaceutisk komposition bestaaende av vattensvaellbar vattenoloeslig polymer fylld med metylhydroxiprogesteronacetat (map) samt foerfarande foer dess framstaellning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8500553D SE8500553L (sv) 1984-02-08 1985-02-06 Pharmaceutical composition

Country Status (32)

Country Link
US (1) US4632828A (nl)
JP (1) JPS60181017A (nl)
KR (1) KR930009897B1 (nl)
AT (1) AT388869B (nl)
AU (1) AU577351B2 (nl)
BE (1) BE901664A (nl)
BG (1) BG60524B2 (nl)
CA (1) CA1240928A (nl)
CH (1) CH664693A5 (nl)
CZ (1) CZ277728B6 (nl)
DE (1) DE3503679A1 (nl)
DK (1) DK164149C (nl)
ES (3) ES8607984A1 (nl)
FI (1) FI84230C (nl)
FR (1) FR2559065B1 (nl)
GB (2) GB8403360D0 (nl)
GR (1) GR850312B (nl)
HK (1) HK94290A (nl)
HU (1) HU194050B (nl)
IE (1) IE58230B1 (nl)
IL (1) IL74241A (nl)
IT (1) IT1209615B (nl)
NL (1) NL192780C (nl)
NO (1) NO170568C (nl)
NZ (1) NZ211058A (nl)
PT (1) PT79933B (nl)
SE (2) SE8500553L (nl)
SG (1) SG80390G (nl)
SK (1) SK278084B6 (nl)
SU (1) SU1605926A3 (nl)
UA (1) UA6028A1 (nl)
ZA (1) ZA85943B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
GB8806367D0 (en) * 1988-03-17 1988-04-13 Erba Carlo Spa Siloxane matrices with internal non-uniform drug distribution
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
AUPS244002A0 (en) * 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
JP2005094910A (ja) * 2003-09-17 2005-04-07 Aruze Corp モータ停止制御装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
AU454482B2 (en) * 1970-11-05 1974-10-15 Alza Corporation Drug-delivery system
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
DE3006635A1 (de) * 1980-02-22 1981-08-27 Basf Ag, 6700 Ludwigshafen Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
DE3125178A1 (de) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3205399A1 (de) * 1982-02-16 1983-08-25 Bayer Ag, 5090 Leverkusen Feste, schnellfreisetzende arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
EP0084190A3 (en) * 1981-12-08 1984-11-28 Fisons Plc Medicinal composition, package and method of making the composition
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss

Also Published As

Publication number Publication date
KR930009897B1 (ko) 1993-10-13
FR2559065B1 (fr) 1988-09-09
NO170568C (no) 1992-11-04
FI850455L (fi) 1985-08-09
DK57085A (da) 1985-08-09
FR2559065A1 (fr) 1985-08-09
PT79933A (en) 1985-03-01
SE8500553D0 (sv) 1985-02-06
GB2153677B (en) 1988-04-13
JPH0415769B2 (nl) 1992-03-19
ZA85943B (en) 1985-10-30
FI850455A0 (fi) 1985-02-04
NO850477L (no) 1985-08-09
AU3848885A (en) 1985-08-15
AU577351B2 (en) 1988-09-22
GB8403360D0 (en) 1984-03-14
GR850312B (nl) 1985-06-05
DK57085D0 (da) 1985-02-07
IE850261L (en) 1985-08-08
HUT37890A (en) 1986-03-28
PT79933B (en) 1987-02-02
KR850005858A (ko) 1985-09-26
SG80390G (en) 1990-11-23
UA6028A1 (uk) 1994-12-29
ES550613A0 (es) 1987-02-16
IT8519385A0 (it) 1985-02-05
DE3503679C2 (nl) 1992-05-07
SE8500553L (sv) 1985-08-09
NL8500323A (nl) 1985-09-02
IL74241A0 (en) 1985-05-31
NZ211058A (en) 1988-09-29
SU1605926A3 (ru) 1990-11-07
IE58230B1 (en) 1993-08-11
GB8503033D0 (en) 1985-03-06
IT1209615B (it) 1989-08-30
CS78485A3 (en) 1992-11-18
GB2153677A (en) 1985-08-29
ES8703277A1 (es) 1987-02-16
ES8703278A1 (es) 1987-02-16
ES8607984A1 (es) 1986-06-01
DE3503679A1 (de) 1985-08-08
HK94290A (en) 1990-11-23
NO170568B (no) 1992-07-27
CH664693A5 (de) 1988-03-31
NL192780B (nl) 1997-10-01
ES539874A0 (es) 1986-06-01
CZ277728B6 (en) 1993-04-14
BE901664A (fr) 1985-08-06
DK164149C (da) 1992-10-12
US4632828A (en) 1986-12-30
ATA31685A (de) 1989-02-15
FI84230C (fi) 1991-11-11
FI84230B (fi) 1991-07-31
IL74241A (en) 1988-12-30
ES550614A0 (es) 1987-02-16
CA1240928A (en) 1988-08-23
HU194050B (en) 1988-01-28
AT388869B (de) 1989-09-11
DK164149B (da) 1992-05-18
BG60524B2 (bg) 1995-07-28
JPS60181017A (ja) 1985-09-14
SK278084B6 (en) 1995-12-06
NL192780C (nl) 1998-02-03

Similar Documents

Publication Publication Date Title
SE462547B (sv) Farmaceutisk komposition bestaaende av vattensvaellbar vattenoloeslig polymer fylld med metylhydroxiprogesteronacetat (map) samt foerfarande foer dess framstaellning
JPH0717496B2 (ja) 医薬組成物
TWI234465B (en) Stable complexes of poorly soluble compounds
JP3722293B2 (ja) 新規な薬学的固体分散物
CN103459430B (zh) 生产具有高堆积密度和良好流动性的纤维素衍生物的方法
JP6522853B2 (ja) Ｓｏｍｃｌ−９１１２固体分散体、その製造方法およびそれを含むｓｏｍｃｌ−９１１２固体製剤
EP0552708A1 (en) Method of producing a solid dispersion of a sparingly water-soluble drug
WO2008055966A1 (en) Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
JP2001515029A (ja) 粒状分散形態の固形医薬剤形
JP5232472B2 (ja) 向上された生体利用効率を備えるプランルカスト固体分散体組成物およびその固体分散体の製造方法
CN104602673A (zh) 包含高度取代的羟基烷基甲基纤维素的固体分散体
JP2001521010A (ja) 特異な粒度分布を有するカラギーナンと水溶性薬物の複合体および比較制御放出医薬組成物
TW200909006A (en) Pharmaceutical composition and process
CN104510707A (zh) 一种泊沙康唑固体分散体及其制备方法
JP3904617B2 (ja) 緩下剤組成物の製造方法
WO2007141806A1 (en) Pharmaceutical formulations comprising oxcarbazepine and methods thereof
GB2153676A (en) Pharmaceutical composition
CN108653206A (zh) 一种黄芩素纳米混悬剂及其制备方法
KR102539414B1 (ko) 저분자량의 양친성 블록 공중합체를 포함하는 나노입자의 제조 방법
CN107496367A (zh) 一种染料木素纳米共聚物胶束冻干粉的制备方法和应用
EP0682946B1 (en) Laxative compositions
CN107714676A (zh) 恩替卡韦口腔速溶膜剂及其制备方法
WO2004113424A1 (ja) 難水溶性物質と水溶性高分子との共沈物の製造方法
Singh Design and development of drug delivery systems for immediate and sustained release utilizing hot melt extrusion
AU2013228033A1 (en) Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8500553-6

NUG Patent has lapsed